Desjardins Analysts Give Kits Eyecare (TSE:KITS) a C$23.00 Price Target

Desjardins set a C$23.00 price target on Kits Eyecare (TSE:KITSFree Report) in a research report report published on Monday morning,BayStreet reports. The brokerage currently has a buy rating on the stock.

A number of other analysts also recently issued reports on the stock. Stifel Nicolaus cut their price objective on shares of Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Canaccord Genuity Group cut their price target on Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Finally, ATB Cormark Capital Markets dropped their price target on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating on the stock in a report on Thursday, May 7th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of C$20.69.

Get Our Latest Stock Analysis on KITS

Kits Eyecare Trading Down 2.0%

KITS opened at C$15.88 on Monday. The stock has a 50 day moving average of C$14.27. The firm has a market cap of C$540.02 million, a price-to-earnings ratio of 99.25 and a beta of 0.06. Kits Eyecare has a twelve month low of C$10.61 and a twelve month high of C$22.56.

Kits Eyecare (TSE:KITSGet Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$0.04 EPS for the quarter. The firm had revenue of C$58.43 million during the quarter.

Insider Transactions at Kits Eyecare

In other news, insider Joseph Thompson sold 75,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of C$13.65, for a total transaction of C$1,023,750.00. Following the transaction, the insider owned 960,114 shares of the company’s stock, valued at approximately C$13,105,556.10. This represents a 7.25% decrease in their ownership of the stock.

About Kits Eyecare

(Get Free Report)

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Featured Stories

Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.